These associations were observed across all HR/HER2-defined subtypes.<h4>Interpretation</h4>Population-based screening is strongly associated with earlier-stage breast cancer at diagnosis, consistently across all immunohistochemistry subtypes. Here, ERBB2 is linked to breast carcinoma.